This comprehensive approach for assessing and addressing potential cardiac complications before prescribing psychotropics can enhance care.
Diagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.
How effective are these agents for AUD treatment? An expert shares highlights from his 2024 ASCP Annual Meeting Pharmaceutical Pipeline Update presentation.
1 in 6 people with opioid use disorder experience a new traumatic event every month, but no evidence-based treatment for trauma.
Mental health providers who battle a pandemic may find that it unsettles their deepest sense of self.
The emergence of epigenetic models has generated a surge of optimism, opening new possibilities for psychiatric intervention.
Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.
There is a growing effort to standardize the evaluation and management of pediatric SSRDs, which have been reported as the second most common reason for consultation after suicide assessments.
Fire setting is the current preferred term in the literature to describe acts of deliberately started fires regardless of their legal or diagnostic status.
What is a safety plan, and how can clinicians use it to help patients with suicidal behavior?
Brain health disorders cost the global economy more than $3 trillion per year in lost productivity. What can we do about it?
How can we face the current pandemic while addressing the brain health crisis?
Here’s why we should be paying special attention to women's depression treatment.
Isolated older adults may be especially vulnerable to addiction issues with the onset of the pandemic. Here’s how telemedicine can help.
Every phase of the COVID-19 pandemic brings new ethical challenges.
Michael F. Myers, MD, discusses issues of gender and sexuality, both today and in recent psychiatric history.
The development of the National Pediatric Boarding Consensus Panel guidelines attempts to provide hospitals suggestions for a safe, timely, and equitable standard of care for patients who are boarding.
Some psychiatric medications that can trigger Torsades de Pointes (TdP), a potentially fatal polymorphic ventricular tachycardia that arises during abnormal ventricular repolarization. Are you aware of the risk factors that increase risk of TdP?
"This pandemic represents an unprecedented time that requires a psychiatrist’s vigilance in identifying patients at risk for COVID-19–induced psychosis."
The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Explore the relationship between cannabis use and psychosis.
Learn more about a feasible, scalable, effective model of care that is a step away from the forced dichotomy of inpatient and outpatient care.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Every phase of the COVID-19 pandemic brings new ethical challenges.
A psychoanalyst shares her experience working with patients whose lives are marked by poverty, migration, and race and gender discrimination.
What is the psychiatric impact of the current war in Gaza?
"When I was very young and dreaming of becoming a doctor, I never witnessed a physician open up about their mental health, let alone admit to taking medication for it..."
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Psychedelics: it is time to integrate this treatment option into clinical care while holding fast to the principles of medical ethics.